USPTO serial 75559263
MACROGEN
Reviewed by CopyMark Law Group
Reg. 2499317Status 710
- Filing date
- Status date
- Registration date
- Oct 23, 2001
- Examiner
- DALIER, JOHN DAVID
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MACROGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NEW YORK, NY
NEW YORK, NY
Oxford, OX4 4GA, GB
Oxford, OX4 4GA, GB
Oxford, OX4 4GA, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donald N. Huff
CLAUDIA A SMITH ESQ WILMER CUTLER PICKERING HALE & DORR LL399 PARK AVENEW YORK, NY 10022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and gene therapy preparations; chemical compositions containing nucleic acids for specific and industrial research use, enzymes for use in the manufacture of pharmaceuticals and gene therapy preparations, in vitro chemical reagents for scientific or medical research use for analysis, microorganisms, cell cultures, plasmids and cultures in microorganisms, deo-oxyribonucleic acids sequences, cloning vehicles and recombinant deo-oxyribonucleic acid variations thereof, all for in vivo use; and chemical compositions containing enzymes for use in the manufacture of pharmaceuticals and gene therapy preparation | SECTION 8 - CANCELLED | — |
| 005 | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem | SECTION 8 - CANCELLED | — |
| 042 | scientific and medical research and development; medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology and gene therapy | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EYETECH PHARMACEUTICALS, INC.
- Other trademarks owned by (OSI) EYETECH, INC.
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MACROGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2008 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 18, 2007 | CFIT | CASE FILE IN TICRS | — |
| Nov 8, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 16, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 23, 2001 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 9, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 5, 2001 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Feb 2, 2001 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 25, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 1999 | DOCK | ASSIGNED TO EXAMINER | — |